nocodazole has been researched along with Leukemia, T-Cell in 3 studies
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, CR | 1 |
Jun, do Y | 1 |
Lee, JY | 1 |
Kim, YH | 1 |
Kasai, T | 1 |
Iwanaga, Y | 1 |
Iha, H | 1 |
Jeang, KT | 1 |
Nordstedt, C | 1 |
Kvanta, A | 1 |
Fredholm, BB | 1 |
3 other studies available for nocodazole and Leukemia, T-Cell
Article | Year |
---|---|
Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; bcl-2 Homologous Antagonist-Killer Protein; Bcl-2-Like Pro | 2014 |
Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Transformed; Cell Nucleus; Cell Survival; Cy | 2002 |
Agonist but not phorbol ester induced desensitization of human lymphocyte prostaglandin receptor is dependent on tubulin polymerization.
Topics: Benzimidazoles; Binding, Competitive; Carcinogens; Colchicine; Cyclic AMP; Dinoprostone; Humans; Leu | 1988 |